Orient Technologies (NSE: ORIENTTECH) Q3 FY26 results: Why short-term margin pain may be the price of securing long-cycle government and services revenue
Read More 5 minute read Pharma Industry News Formation Bio hires ex-Pfizer and BenevolentAI leaders to supercharge its AI-driven drug development model Formation Bio bolsters its leadership team with top biotech and pharma veterans to fast-track its AI-driven drug development model. bySoujanya RaviSeptember 18, 2025